PennyStockPayCheck.com Rss

Featured Posts

Chase Bank Limits Cash Withdrawals, Bans International... Before you read this report, remember to sign up to http://pennystockpaycheck.com for 100% free stock alerts Chase Bank has moved to limit cash withdrawals while banning business customers from sending...

Read more

Richemont chairman Johann Rupert to take 'grey gap... Billionaire 62-year-old to take 12 months off from Cartier and Montblanc luxury goods groupRichemont's chairman and founder Johann Rupert is to take a year off from September, leaving management of the...

Read more

Cambodia: aftermath of fatal shoe factory collapse... Workers clear rubble following the collapse of a shoe factory in Kampong Speu, Cambodia, on Thursday

Read more

Spate of recent shock departures by 50-something CEOs While the rising financial rewards of running a modern multinational have been well publicised, executive recruiters say the pressures of the job have also been ratcheted upOn approaching his 60th birthday...

Read more

UK Uncut loses legal challenge over Goldman Sachs tax... While judge agreed the deal was 'not a glorious episode in the history of the Revenue', he ruled it was not unlawfulCampaign group UK Uncut Legal Action has lost its high court challenge over the legality...

Read more

Addex Shareholders Approve All Board Proposals at Annual General Meeting

Category : Stocks

GENEVA–(Marketwire – Mar 20, 2013) – Addex Therapeutics / Addex Shareholders Approve All
Board Proposals at Annual General Meeting. Processed and transmitted by
Thomson Reuters ONE.

Continue reading here: Addex Shareholders Approve All Board Proposals at Annual General Meeting

Post to Twitter

Thomson delays start of 787 flights

Category : Business

Thomson cancels plans to start services using Boeing’s 787 Dreamliner planes in May, transferring long-haul passengers to its 767 aircraft.

Read more: Thomson delays start of 787 flights

Post to Twitter

MorphoSys and Heptares Sign Alliance to Develop Antibody Therapeutics Targeting GPCRs

Category : Stocks

MARTINSRIED, GERMANY and MUNICH, GERMANY–(Marketwire – Feb 13, 2013) – MorphoSys AG /
MorphoSys and Heptares Sign Alliance to Develop Antibody Therapeutics
Targeting
GPCRs. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.

See the original post here: MorphoSys and Heptares Sign Alliance to Develop Antibody Therapeutics Targeting GPCRs

Post to Twitter

Barry Callebaut: Strong first quarter: +8.3% volume growth

Category : World News

ZURICH, SWITZERLAND–(Marketwire – Jan 16, 2013) – Barry Callebaut /
Barry Callebaut: Strong first quarter: +8.3% volume growth
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.

Read more: Barry Callebaut: Strong first quarter: +8.3% volume growth

Post to Twitter

Addex Announces Positive Data with ADX71441 in a Pre-Clinical Transgenic Model of Charcot-Marie-Tooth 1A Disease

Category : Stocks

GENEVA–(Marketwire – Jan 7, 2013) – Addex Therapeutics /
Addex Announces Positive Data with ADX71441 in a Pre-Clinical Transgenic
Model
of Charcot-Marie-Tooth 1A Disease
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.

Read more: Addex Announces Positive Data with ADX71441 in a Pre-Clinical Transgenic Model of Charcot-Marie-Tooth 1A Disease

Post to Twitter

Basilea reports recruitment completion of phase 3 pivotal study of isavuconazole, an agent for the potential primary treatment of invasive and life-threatening fungal infections

Category : World News

BASEL, SWITZERLAND–(Marketwire – Dec 14, 2012) – Basilea Pharmaceutica AG /
Basilea reports recruitment completion of phase 3 pivotal study of
isavuconazole, an agent for the potential primary treatment of invasive and
life-threatening fungal infections
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.

View original post here: Basilea reports recruitment completion of phase 3 pivotal study of isavuconazole, an agent for the potential primary treatment of invasive and life-threatening fungal infections

Post to Twitter

Barry Callebaut: Previous Q1 restated figures due to consumer divestment

Category : World News

ZURICH, SWITZERLAND–(Marketwire – Dec 11, 2012) – Barry Callebaut /
Barry Callebaut: Previous Q1 restated figures due to consumer divestment
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.

Read more: Barry Callebaut: Previous Q1 restated figures due to consumer divestment

Post to Twitter

MorphoSys Strengthens Patent Position on anti-CD38 Cancer Program MOR202

Category : World News

MARTINSRIE, GERMANY and MUNICH, GERMANY–(Marketwire – Dec 6, 2012) – MorphoSys AG /
MorphoSys Strengthens Patent Position on anti-CD38 Cancer Program MOR202
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.

Original post: MorphoSys Strengthens Patent Position on anti-CD38 Cancer Program MOR202

Post to Twitter

MorphoSys and Lanthio Pharma Sign Technology Alliance on New Class of Therapeutic Peptides

Category : World News

MARTINSRIED, GERMANY and MUNICH, GERMANY–(Marketwire – Nov 27, 2012) – MorphoSys AG /
MorphoSys and Lanthio Pharma Sign Technology Alliance on New Class of
Therapeutic Peptides. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.

Go here to read the rest: MorphoSys and Lanthio Pharma Sign Technology Alliance on New Class of Therapeutic Peptides

Post to Twitter

MorphoSys AG Reports Nine Months 2012 Results

Category : World News

MARTINSRIED, GERMANY and MUNICH, GERMANY–(Marketwire – Nov 7, 2012) – MorphoSys AG /
MorphoSys AG Reports Nine Months 2012 Results
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.

Read the rest here: MorphoSys AG Reports Nine Months 2012 Results

Post to Twitter